ISSCR News
Ninth Circuit Reverses Lower Court, Reinforces FDA’s Authority to Regulate Unproven Stem Cell Products
In an important step to protect the public from unproven stem cell products, the U.S. Court of Appeals for the Ninth Circuit ruled in favor of the U.S. Food and Drug Administration in U.S. v. California Stem Cell Treatment Center, Inc., reversing the district court. The reversal fortifies FDA’s tiered, risk-based framework for the regulation of cell therapies and is consistent with a similar ruling in the Eleventh Circuit in 2021.
Scientists Aim to Decode the Genetic Roots of Mental Illness on a Large Scale
Neurodevelopmental and psychiatric disorders (NPD) including schizophrenia, bipolar disorder, autism, and depression are detrimental to individuals, their families and society as a whole, and in many cases still lack effective treatments. It’s becoming more and more clear that genetic mutations in certain genes can increase the likelihood of developing NPD, and several hundreds of those “risk genes” have been identified to date, but their role related to NPD remains a mystery.
New Podcast Episode. Aging, Stem Cells, and Biological Clocks
In this episode of The Stem Cell Report, Martin Pera is joined by Konrad Hochedlinger, PhD, and Rebecca Gorelov, PhD, to discuss their recent publication in Stem Cell Reports. Epigenetic clocks are promising biomarkers of aging, but little is known about their cellular basis.
Member Spotlight: Mariaceleste Aragona, PhD
Engaging in stimulating scientific discussions with scientists from various fields and learning new things every day motivates me. I find it very rewarding when other researchers build on my experiments or conclusions.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .